Moderna’s Shift to Cancer Company Lifts Stock Up 177%
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
from NYT > Health https://ift.tt/gaFHMv2
via IFTTT
from NYT > Health https://ift.tt/gaFHMv2
via IFTTT

No comments